Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathwaysBailin He, Na Xu, Hongsheng Zhou et al.|Experimental Hematology and Oncology|2025Cited by 6